Abstract
c-Jun N-terminal kinase (JNK), known as a stress-activated protein kinase, regulates normal epithelial biological processes, including assembly of adherens and tight junctions, and it is involved in the development of several cancers. The JNK inhibitor SP600125 enhances epithelial barrier function through modulation of tight junction molecules in normal human pancreatic epithelial cells. Furthermore, this JNK inhibitor suppresses the growth of human pancreatic cancer cells. However, the effects of SP600125 on the epithelial barrier in human pancreatic cancer cells remain unknown. In the present study, the JNK inhibitor SP600125 markedly enhanced the barrier function and cell elongation of well-differentiated human pancreatic cancer cell line HPAC in a Ca-switch model. The epithelial barrier function induced by SP600125 was regulated by phosphorylated β-catenin without changes in the tight junction molecules. The cell elongation induced by SP600125 was closely related to the expression of the F-actin-binding protein DrebrinE. These findings suggest that JNK is involved in the regulation of the epithelial barrier function and cell shape during remodeling of pancreatic cancer cells. The JNK inhibitor SP600125 may have potential as a therapeutic drug for pancreatic cancer via induction of differentiation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bazellières E, Massey-Harroche D, Barthélémy-Requin M, Richard F, Arsanto JP, Le Bivic A (2012) Apico-basal elongation requires a drebrin-E-EB3 complex in columnar human epithelial cells. J Cell Sci 125:919–931
Bennett BL, Sasaki DT, Murray BW, O’Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681–13686
Carrozzino F, Pugnale P, Féraille E, Montesano R (2009) Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression. Am J Physiol Cell Physiol 297:C775–C787
Chen N, Nomura M, She QB, Ma WY, Bode AM, Wang L, Flavell RA, Dong Z (2001) Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 61:3908–3912
Chen YH, Lu Q, Goodenough DA, Jeansonne B (2002) Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 13:1227–1237
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239–252
Dun XP, Chilton JK (2010) Control of cell shape and plasticity during development and disease by the actin-binding protein Drebrin. Histol Histopathol 25:533–540
Ebelt ND, Cantrell MA, Van Den Berg CL (2013) c-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade. Genes Cancer 4:378–387
Ebnet K (2008) Organization of multiprotein complexes at cell–cell junctions. Histochem Cell Biol 130:1–20
Gazel A, Banno T, Walsh R, Blumenberg M (2006) Inhibition of JNK promotes differentiation of epidermal keratinocytes. J Biol Chem 281:20530–20541
Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ (2007) Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin Cancer Res 13:5910–5917
Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF (2008) Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 118:3943–3953
Karin M, Gallagher E (2005) From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57:283–295
Kojima T, Fuchimoto J, Yamaguchi H, Ito T, Takasawa A, Ninomiya T, Kikuchi S, Ogasawara N, Ohkuni T, Masaki T, Hirata K, Himi T, Sawada N (2010) c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol 225:720–733
Kojima T, Yamaguchi H, Ito T, Kyuno D, Kono T, Konno T, Sawada N (2013) Tight junctions in human pancreatic duct epithelial cells. Tissue Barriers 1:e24894
Lee MH, Koria P, Qu J, Andreadis ST (2009) JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J 23:3874–3883
Lee MH, Padmashali R, Koria P, Andreadis ST (2011) JNK regulates binding of alpha-catenin to adherens junctions and cell–cell adhesion. FASEB J 25:613–623
Naydenov NG, Hopkins AM, Ivanov AI (2009) c-Jun N-terminal kinase mediates disassembly of apical junctions in model intestinal epithelia. Cell Cycle 8:2110–2121
Samak G, Suzuki T, Bhargava A, Rao RK (2010) c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction disruption in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 299:G572–G584
Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B, Behrens A (2009) JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 28:1843–1854
Shibata W, Maeda S, Hikiba Y, Yanai A, Sakamoto K, Nakagawa H, Ogura K, Karin M, Omata M (2008) c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res 68:5031–5039
Shirao T, Obata K (1985) Two acidic proteins associated with brain development in chick embryo. J Neurochem 44:1210–1216
Takahashi R, Hirata Y, Sakitani K, Nakata W, Kinoshita H, Hayakawa Y, Nakagawa H, Sakamoto K, Hikiba Y, Ijichi H, Moses HL, Maeda S, Koike K (2013) Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci 104:337–344
Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285–293
Vacca B, Bazellières E, Nouar R, Harada A, Massey-Harroche D, Le Bivic A (2014) Drebrin E depletion in human intestinal epithelial cells mimics Rab8a loss of function. Hum Mol Genet 23:2834–2846
Volberg T, Geiger B, Kartenbeck J, Franke WW (1986) Changes in membrane-microfilament interaction in intercellular adherens junctions upon removal of extracellular Ca2+ ions. J Cell Biol 102:1832–1842
Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19:142–149
Whatcott C, Han H, Posner RG, Von Hoff DD (2013) Tumor–stromal interactions in pancreatic cancer. Crit Rev Oncog 18:135–151
Yang YM, Bost F, Charbono W, Dean N, McKay R, Rhim JS, Depatie C, Mercola D (2003) C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin Cancer Res 9:391–401
You H, Lei P, Andreadis ST (2013) JNK is a novel regulator of intercellular adhesion. Tissue Barriers 1:e26845
Acknowledgments
This work was supported by the Ministry of Education, Culture, Sports Science, and Technology, and the Ministry of Health, Labour and Welfare of Japan.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Konno, T., Ninomiya, T., Kohno, T. et al. c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model. Histochem Cell Biol 143, 471–479 (2015). https://doi.org/10.1007/s00418-014-1300-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-014-1300-4